AVI BioPharma Announces Positive Clinical Trial Results Delivering NEUGENE Antisense Drugs to the Central Nervous System.
Business Wire › November 10, 2006
Linked as:
Extract
AVI BioPharma Announces Positive Clinical Trial Results Delivering NEUGENE Antisense Drugs to the Central Nervous System.
Antisense drugs targeting hepatitis C virus, West Nile virus, and the oncogene c-myc found in the CSF after systemic administration to humans
PORTLAND, Ore. -- AVI BioPharma, Inc. (Nasdaq:AVII), today announced human clinical trial results s...See the full content of this document
Sponsored links
